Chemkart India Limited has filed its second monitoring agency report with BSE, detailing the utilization of funds raised through its Initial Public Offering (IPO) for the quarter ended December 31, 2025. The report, prepared by Brickwork Ratings India Private Limited, confirms compliance with regulatory requirements and proper deployment of IPO proceeds.

IPO Details and Fund Raising

The company successfully raised Rs 80.08 crore through its IPO conducted from July 7, 2025, to July 9, 2025. The issue comprised both fresh equity shares and offer for sale components.

Fund Utilization Progress

The monitoring agency report reveals significant progress in the deployment of IPO proceeds across the stated objectives. The funds are being utilized for four primary purposes as outlined in the offer document.

Key Developments and Compliance

The monitoring agency confirmed that all fund utilization aligns with disclosures made in the offer document. No material deviations were observed, and all necessary government and statutory approvals related to the stated objectives have been obtained. The company has completed its debt repayment objective entirely, utilizing the full Rs 20.00 crore allocated for this purpose.

For the manufacturing facility investment through its wholly-owned subsidiary Easy Raw Materials Private Limited, the company has utilized Rs 1.45 crore out of the allocated Rs 34.68 crore, with Rs 0.96 crore deployed during the quarter ended December 31, 2025.

Deployment of Unutilized Funds

The company has invested its unutilized IPO proceeds in various mutual fund schemes and bank deposits to optimize returns while maintaining liquidity. The investments include arbitrage funds and liquid funds from leading asset management companies.

Regulatory Compliance and Timeline

The report confirms no delays in the implementation of stated objectives. The manufacturing facility investment is progressing as planned with completion targeted by Financial Year 2026-27. All regulatory requirements under SEBI ICDR Regulations have been met, with proper documentation and certification provided by chartered accountants.

The monitoring agency noted that during the previous quarter ended September 30, 2025, there was an additional outflow of Rs 0.29 crore towards offer for sale shareholders beyond the amount specified in the prospectus, primarily due to issue-related expenses.

Chemkart India Limited has issued a corrigendum to the BSE to correct the name of its Company Secretary and Compliance Officer following a post-marriage name change. The correction addresses an error in the company's original regulatory filing dated January 20, 2026.

Name Correction Details

The company filed the corrigendum on February 3, 2026, to rectify the last name of the appointed Company Secretary and Compliance Officer. The correction was necessary because the original disclosure contained the officer's maiden name rather than her married name.

Regulatory Compliance

The corrigendum was submitted under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company clarified that wherever "Shreya Agarwal" appears in the original disclosure dated January 20, 2026, it should be read as "Shreya Dalmia."

Unchanged Information

Chemkart India Limited emphasized that except for the name correction, all other information and details mentioned in the original disclosure dated January 20, 2026, remain unchanged. The appointment terms, responsibilities, and effective date of January 20, 2026, continue as originally disclosed.

The corrigendum was signed by Ankit Shailesh Mehta, Chairman & Managing Director (DIN: 06792217), and submitted to BSE Limited under scrip code 544442.